← All companies

ANIK

Anika Therapeutics, Inc.

ANIK Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$20.74

+2.67 +14.75%

Key statistics

from XBRL data in SEC filings

Market cap

$277M

Revenue (TTM)

$121M

Net income (TTM)

-$3.90M

EPS (TTM)

$-0.27

P/E ratio

—

Dividend yield

—

Free cash flow

$4.36M

Cash

$38.4M

Total assets

$183M

Gross margin

62.2%

52-week range

$7.92 – $21.12

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jul 14, 2026 8-K Director or officer change; Shareholder vote results Jun 23, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Director or officer change Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release); Director or officer change Feb 26, 2026 8-K Results of operations (earnings release); Director or officer change Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release); Other events Nov 5, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K Regulation FD disclosure Jul 30, 2025 8-K Director or officer change; Shareholder vote results Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 9, 2025 8-K Director or officer change Apr 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 12, 2025 8-K Completed an acquisition or disposition; Regulation FD disclosure Mar 11, 2025 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K Completed an acquisition or disposition; Regulation FD disclosure Oct 31, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jul 11, 2024 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure May 28, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Director or officer change May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 26, 2024 10-K Fiscal year ended 2023-12-31 Mar 15, 2024 8-K Results of operations (earnings release) Mar 13, 2024 8-K Director or officer change Feb 26, 2024 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Results of operations (earnings release) Nov 2, 2023 8-K Regulation FD disclosure Sep 21, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release) Aug 8, 2023